"Family owned Clinical Research site where you are more than a participant, you are an individual we care about. Opportunities to participate in cutting edge therapies while being ministered to as an individual."

During the past decade, Peninsula Research, Inc conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 19 clinical trials were completed, i.e. on average, 475% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Research, Inc" #1 sponsor was "Purdue Pharma LP" with 6 trials, followed by "BioDelivery Sciences International" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Iroko Pharmaceuticals, LLC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Research, Inc" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Research, Inc" are "Osteoarthritis" (5 trials), "Low Back Pain" (4 trials), "Back Pain Lower Back Chronic" (3 trials), "Cardiovascular Disease" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Peninsula Research, Inc" in a lesser frequency.

Most popular intervention types in "Peninsula Research, Inc" are "Drug" (25 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Buprenorphine" (4 trials), "Diclofenac" (2 trials), "Empagliflozin" (2 trials) and "Gan & Lee Insulin Glargine Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Research, Inc" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Peninsula Research, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Peninsula Research, Inc, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Research, Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".